Target intelligence / Profile preview

Semaphorin 4C (SEMA4C)

Target
SEMA4C
Molecular classification
Receptor (cell surface receptor, based on its semaphorin function and transmembrane topology), Member of the Semaphorin family (class 4 Semaphorin based on structure and evolutionary grouping), Contains a sema domain, immunoglobulin (Ig) domain, transmembrane (TM) domain, and short cytoplasmic tail, Ligand for Plexin-B2 (indicates roles in the semaphorin–plexin signaling pathway)
01

Overview

Semaphorin 4C (SEMA4C) is a type I transmembrane protein belonging to the class 4 semaphorin family, characterized by the presence of a sema domain, immunoglobulin-like domain, transmembrane domain, and short cytoplasmic tail. SEMA4C functions as a guidance cue in development, regulating cell migration, adhesion, and cytoskeleton dynamics through its interaction with Plexin-B2 and other intracellular partners such as CRMP3. It is expressed at elevated levels in certain cancers, promoting tumor cell motility, invasion, and immunosuppression via PD-L1 regulation. In the immune system, SEMA4C supports B-cell polarization and antibody production, impacting lymphoid follicle formation and synapse organization. Experimental targeting of SEMA4C with neutralizing antibodies or microRNA reduces metastatic behavior and attenuates related immunosuppressive pathways, indicating its value as a potential therapeutic target in oncology and immunology.

Other names
Semaphorin-4CSEMA4CKIAA1739SEMAlUNQ5855/PRO34487Semacl1SemafM-Sema FSEMACL1SEMAFsema domain immunoglobulin domain (Ig) transmembrane domain (TM) and short cytoplasmic domain(semaphorin) 4C
02

Mechanism of action

Neutralizing antibody blocks SEMA4C, reducing cancer cell motility and invasion through suppression of tubulin deacetylation and cell adhesion pathways Reduces immunosuppressive activity via attenuation of PD-L1 expression Synergistic suppression with let-7b microRNA (targets SEMA4C for downregulation)

03

Biological functions

Signal transduction (semaphorin–plexin signaling)Regulation of cell motility and migration, especially in cancer (promotes cell movement and invasion)Regulation of cell adhesion, cytoskeleton organization, and focal adhesionChemorepellent activity (guidance cue function in neural and immune systems)Muscle cell differentiationPositive regulation of stress-activated MAPK cascadeImmune response (specifically B-cell polarization and formation of immune synapse)
04

Disease associations

Cancer (implicated in tumor motility, invasion, and progression, especially colon cancer)Inflammation and immune regulation (B-cell function, antibody production, lymphoid follicle development)Neurological development (neuron guidance, synaptic signaling)Myasthenic Syndrome, Congenital, 13Intraorbital Meningioma
05

Safety considerations

Potential for on-target effects due to its physiological roles in neural development and immune system (neuronal guidance, immune synapse formation)Unknown long-term effects of SEMA4C blockade in humans, as research is mostly preclinical
06

Interacting drugs

SEMA4C neutralizing antibody (experimental, used in preclinical studies to block SEMA4C in colon cancer models)
07

Biomarkers

SEMA4C expression (prognostic biomarker for poor survival in colon cancer)Let-7b microRNA (targeting SEMA4C)Co-expression of PD-L1 as a potential marker of immunosuppression

Beyond the preview

Go deeper on Semaphorin 4C (SEMA4C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Semaphorin 4C (SEMA4C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call